Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, July 3, 2024

Highlights of the 2024 European Stroke Organization Conference

 Look at that! NOTHING ON GETTING SURVIVORS RECOVERED! You would think with stroke in the name, it would be about helping stroke survivors! 22 minute podcast, I'm not listening.

Highlights of the 2024 European Stroke Organization Conference

Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about recent trials presented at the European Stroke Organization Conference.

Show references: 

Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy 

Rationale and Design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III)

Colchicine for Prevention of Vascular Inflammation in Non-CardioEmbolic Stroke (CONVINCE)

Intensive Ambulance-Delivered Blood- Pressure Reduction in Hyperacute Stroke

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Disclosures can be found at Neurology.org.

Andrew M. Southerland, MD, MSc, FAHA, FAAN

Editorial Board, Neurology® Education

Andrew M. Southerland is a Harrison Distinguished Teaching Professor of Neurology and Public Health Sciences at the University of Virginia. He received his M.D. as a Brody Scholar from the Brody School of Medicine at East Carolina University, and completed his Neurology Residency and Vascular Neurology Fellowship at the University of Virginia. He currently serves as Residency Program Director and Executive Vice Chair in the UVA Department of Neurology. Dr. Southerland also serves on the AAN Education Committee and the Editorial Board for Neurology: Education.

Seemant Chaturvedi, MD, FAAN, FAHA

Editorial Board, Neurology®

No comments:

Post a Comment